Peter Reiss Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

1/2021	Cost-effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States.
1/2018	Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study.
11/2017	Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study.
1/2017	Suboptimal primary and secondary cardiovascular disease prevention in HIV-positive individuals on antiretroviral therapy.
1/2016	An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study.
1/2016	Difference in Aortic Stiffness Between Treated Middle-Aged HIV Type 1-Infected and Uninfected Individuals Largely Explained by Traditional Cardiovascular Risk Factors, With an Additional Contribution of Prior Advanced Immunodeficiency.
10/2012	Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.
7/2012	Episodes of HIV viremia and the risk of non-AIDS diseases in patients on suppressive antiretroviral therapy.
7/2011	Elevated triglycerides and risk of myocardial infarction in HIV-positive persons.
10/2010	Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Reiss Research Topics

Disease

61	Acquired Immunodeficiency Syndrome (AIDS) 01/2023 - 07/2002
32	HIV Infections (HIV Infection) 10/2023 - 08/2002
28	Infections 01/2022 - 08/2002
15	Inflammation (Inflammations) 11/2023 - 04/2009
15	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 07/2002
13	Viremia 01/2022 - 05/2008
13	Myocardial Infarction 01/2018 - 11/2003
13	Lipodystrophy 10/2012 - 07/2002
11	Neoplasms (Cancer) 11/2023 - 06/2010
11	Hypertension (High Blood Pressure) 12/2017 - 05/2003
9	Cognitive Dysfunction 01/2020 - 01/2016
9	Insulin Resistance 11/2016 - 02/2003
6	Coinfection 07/2020 - 08/2008
6	Tuberculosis (Tuberculoses) 01/2019 - 12/2005
5	Dyslipidemias (Dyslipidemia) 01/2023 - 04/2007
5	Hepatitis B 01/2019 - 08/2008
5	Coronary Disease (Coronary Heart Disease) 12/2014 - 05/2003
5	Diabetes Mellitus 10/2012 - 05/2003
4	Frailty 01/2021 - 01/2016
4	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2021 - 08/2002
4	Chronic Renal Insufficiency 10/2019 - 04/2012
4	Stroke (Strokes) 08/2019 - 01/2013
4	Disease Progression 07/2014 - 09/2007
3	Weight Gain 10/2023 - 01/2021
3	COVID-19 01/2023 - 01/2022
3	Immune Reconstitution Inflammatory Syndrome 12/2019 - 08/2008
3	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 01/2016
3	Hepatitis C 01/2019 - 01/2005
3	Fibrosis (Cirrhosis) 01/2019 - 07/2012
3	Opportunistic Infections (Opportunistic Infection) 03/2016 - 08/2002
3	Osteoporosis 11/2015 - 02/2013
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2014 - 12/2010
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2010 - 03/2009
2	Anus Neoplasms (Anal Cancer) 01/2023 - 04/2015
2	AIDS Dementia Complex 01/2018 - 03/2011
2	Genetic Predisposition to Disease (Genetic Predisposition) 11/2017 - 01/2012
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2016 - 07/2012
2	Metabolic Bone Diseases (Osteopenia) 11/2015 - 02/2015
2	Renal Insufficiency (Renal Failure) 07/2012 - 07/2002
2	Body Weight (Weight, Body) 07/2010 - 05/2003
2	Atherosclerosis 06/2010 - 07/2007
2	Hypertriglyceridemia 06/2010 - 01/2006

Drug/Important Bio-Agent (IBA)

24	RNA (Ribonucleic Acid)IBA 11/2023 - 04/2003
14	Anti-HIV Agents (AIDS Drugs)IBA 10/2019 - 02/2009
13	LipidsIBA 07/2022 - 07/2002
11	Protease Inhibitors (Protease Inhibitor)IBA 10/2019 - 07/2002
10	abacavir (Ziagen)FDA Link 01/2023 - 07/2004
10	Ritonavir (Norvir)FDA Link 01/2018 - 05/2003
10	Reverse Transcriptase InhibitorsIBA 01/2018 - 02/2003
9	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2008
8	Tenofovir (Viread)FDA Link 01/2023 - 04/2012
8	NucleosidesIBA 01/2018 - 02/2003
8	Lamivudine (Epivir)FDA Link 01/2013 - 07/2007
7	Triglycerides (Triacylglycerol)IBA 01/2017 - 02/2003
6	Lopinavir FDA Link 10/2021 - 02/2010
6	Antihypertensive Agents (Antihypertensives)IBA 01/2018 - 01/2005
6	Atazanavir Sulfate (Reyataz)FDA Link 01/2018 - 01/2013
6	Stavudine (Zerit)FDA LinkGeneric 01/2016 - 06/2004
6	CholesterolIBA 01/2014 - 02/2003
6	Zidovudine (Retrovir)FDA LinkGeneric 04/2012 - 06/2004
6	Nevirapine (Viramune)FDA Link 02/2010 - 07/2002
5	Indinavir (Crixivan)FDA Link 10/2021 - 07/2002
5	CreatinineIBA 01/2017 - 06/2006
5	Mitochondrial DNA (mtDNA)IBA 01/2012 - 06/2004
4	IntegrasesIBA 10/2023 - 01/2021
4	Antiviral Agents (Antivirals)IBA 01/2022 - 07/2012
4	C-Reactive ProteinIBA 01/2021 - 04/2009
4	Didanosine (Videx)FDA LinkGeneric 01/2016 - 09/2007
4	HDL CholesterolIBA 07/2011 - 02/2003
4	Lipoproteins (Lipoprotein)IBA 06/2010 - 07/2002
3	tenofovir alafenamideIBA 10/2023 - 11/2015
3	Glucose (Dextrose)FDA LinkGeneric 07/2022 - 01/2008
3	efavirenz (Sustiva)FDA Link 07/2022 - 10/2016
3	Darunavir (Prezista)FDA Link 10/2021 - 01/2018
3	Indicators and Reagents (Reagents)IBA 06/2021 - 01/2008
3	Lipopolysaccharide ReceptorsIBA 01/2021 - 12/2017
3	AntigensIBA 01/2020 - 04/2009
3	Alanine Transaminase (SGPT)IBA 01/2019 - 02/2013
3	HIV Protease InhibitorsIBA 01/2018 - 01/2006
3	insulin receptor-related receptor (IRR)IBA 01/2012 - 01/2008
2	Immunoglobulin M (IgM)IBA 01/2023 - 01/2022
2	Immunoglobulin G (IgG)IBA 01/2023 - 01/2022
2	Messenger RNA (mRNA)IBA 01/2021 - 11/2016
2	Integrase InhibitorsIBA 01/2021 - 12/2019
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 05/2008
2	dolutegravirIBA 10/2019 - 01/2015
2	Antidepressive Agents (Antidepressants)IBA 01/2018 - 12/2015
2	Emtricitabine (Emtriva)FDA Link 11/2017 - 04/2012
2	Retinaldehyde (Retinal)IBA 03/2016 - 01/2016
2	Anti-Retroviral Agents (Antiretroviral Agents)IBA 01/2016 - 05/2008
2	Nelfinavir (Viracept)FDA Link 01/2016 - 09/2007
2	Surface Antigens (Surface Antigen)IBA 11/2015 - 03/2013
2	N-acetoacetyl-N-deacetylcolchicineIBA 04/2015 - 10/2013
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 03/2013 - 01/2013
2	LDL CholesterolIBA 06/2010 - 02/2003

Therapy/Procedure

72	Therapeutics 10/2023 - 07/2002
60	Highly Active Antiretroviral Therapy (HAART) 11/2021 - 07/2002
22	Art Therapy 11/2023 - 01/2008
2	Liver Transplantation 01/2019 - 01/2016
2	Ambulatory Care (Outpatient Care) 01/2016 - 01/2013